Imipenem Resistance in Salmonella enterica Serovar Wien Related to Porin Loss and CMY-4 β-Lactamase Production

ABSTRACT Two multidrug-resistant Salmonella enterica serovar Wien strains (SW468 and SW1107) were isolated in 2001 in Tunis. Both strains produced the β-lactamases TEM-1, SHV-2a, and CMY-4, whereas strain SW1107 also produced the β-lactamase CTX-M-3. The imipenem-resistant strain (SW468) was totally devoid of the OmpF-immunorelated porin. Imipenem resistance was shown as being related to porin loss and CMY-4 β-lactamase production.

[1]  F. Grimont,et al.  Nosocomial outbreak of acute gastroenteritis in a neonatal intensive care unit in tunisia caused by multiply drug resistantSalmonella wien producing SHV-2 beta-lactamase , 1991, European Journal of Clinical Microbiology and Infectious Diseases.

[2]  M. Gomáriz,et al.  CMY-2-producing Salmonella enterica, Klebsiella pneumoniae, Klebsiella oxytoca, Proteus mirabilis and Escherichia coli strains isolated in Spain (October 1999-December 2000). , 2001, The Journal of antimicrobial chemotherapy.

[3]  M. Jaquinod,et al.  A new mechanism of antibiotic resistance in Enterobacteriaceae induced by a structural modification of the major porin , 2001, Molecular microbiology.

[4]  F. Mostashari,et al.  Emergence of domestically acquired ceftriaxone-resistant Salmonella infections associated with AmpC beta-lactamase. , 2000, JAMA.

[5]  J. Ruiz,et al.  Salmonella enterica Serovar Virchow with CTX-M-Like β-Lactamase in Spain , 2000, Journal of Clinical Microbiology.

[6]  J. Pagés,et al.  Substitutions in the Eyelet Region Disrupt Cefepime Diffusion through the Escherichia coli OmpF Channel , 2000, Antimicrobial Agents and Chemotherapy.

[7]  J. Ruiz,et al.  Salmonella enterica serovar virchow with CTX-M-like beta-lactamase in Spain. , 2000, Journal of clinical microbiology.

[8]  G. French,et al.  Carbapenem Resistance in Escherichia coli Associated with Plasmid-Determined CMY-4 β-Lactamase Production and Loss of an Outer Membrane Protein , 1999, Antimicrobial Agents and Chemotherapy.

[9]  P. Lagrange,et al.  Characterisation of CMY-4, an AmpC-type plasmid-mediated beta-lactamase in a Tunisian clinical isolate of Proteus mirabilis. , 1998, FEMS microbiology letters.

[10]  J. Pagés,et al.  Porin alteration and active efflux: two in vivo drug resistance strategies used by Enterobacter aerogenes. , 1998, Microbiology.

[11]  G. Storch,et al.  CTX-M-5, a Novel Cefotaxime-Hydrolyzing β-Lactamase from an Outbreak of Salmonella typhimuriumin Latvia , 1998, Antimicrobial Agents and Chemotherapy.

[12]  M. Nicolas-Chanoine,et al.  Discriminatory Detection of Inhibitor-Resistant β-Lactamases in Escherichia coli by Single-Strand Conformation Polymorphism-PCR , 1998, Antimicrobial Agents and Chemotherapy.

[13]  A. Medeiros,et al.  Evolution of extended-spectrum beta-lactam resistance (SHV-8) in a strain of Escherichia coli during multiple episodes of bacteremia , 1997, Antimicrobial agents and chemotherapy.

[14]  K. Bush,et al.  Imipenem resistance in Klebsiella pneumoniae is associated with the combination of ACT-1, a plasmid-mediated AmpC beta-lactamase, and the foss of an outer membrane protein , 1997, Antimicrobial agents and chemotherapy.

[15]  O. Gaillot,et al.  Novel transferable beta-lactam resistance with cephalosporinase characteristics in Salmonella enteritidis. , 1997, The Journal of antimicrobial chemotherapy.

[16]  I. Stemplinger,et al.  Characterization of beta-lactamase gene blaPER-2, which encodes an extended-spectrum class A beta-lactamase , 1996, Antimicrobial agents and chemotherapy.

[17]  J. Pagés,et al.  Crucial domains are conserved in Enterobacteriaceae porins. , 1996, FEMS microbiology letters.

[18]  A. Karshikoff,et al.  Electrostatic properties of two porin channels from Escherichia coli. , 1994, Journal of molecular biology.

[19]  P. Nordmann,et al.  Extended-spectrum beta-lactamase in Proteus mirabilis. , 1994, The Journal of antimicrobial chemotherapy.

[20]  G. Rummel,et al.  Crystal structures explain functional properties of two E. coli porins , 1992, Nature.

[21]  P. Courvalin,et al.  Possible in-vivo transfer of beta-lactamase TEM-3 from Klebsiella pneumoniae to Salmonella kedougou. , 1991, The Journal of antimicrobial chemotherapy.